Inhibitor Therapeutics, Inc.

INTI·OTC·$0.08Share Price as of 11/2·$13MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-KFY 202503/26/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report09/18/26 8-KCurrent report04/01/26 8-KCurrent report04/01/26 8-KCurrent report02/24/26 8-KCurrent report10/27/25

Prospectuses and Registrations

POS AMPost-effective amendment04/26/19 POS AMPost-effective amendment04/04/18 POS AMPost-effective amendment04/21/17 S-8Registration of securities for employees10/24/16 424B3Prospectus07/26/16

Proxies

DEF 14ADefinitive proxy08/17/26 DEF 14ADefinitive proxy11/13/17 PREM14APreliminary proxy (merger)10/28/10 PRE 14APreliminary proxy02/02/10 DEF 14ADefinitive proxy09/17/09

Ownership

Form 4Insider transaction08/04/26 Form 4Insider transaction08/04/26 Form 4Insider transaction08/04/26 Form 4Insider transaction08/04/26 Form 4Insider transaction08/04/26

Other

UPLOADLetter from the SEC09/15/25 CORRESPCorrespondence with the SEC07/22/25 UPLOADLetter from the SEC07/17/25 DEF 14CDefinitive information statement12/05/19 DEF 14CDefinitive information statement06/03/19